BROOKDALE SENIOR LIVING INC (BKD) Stock Fundamental Analysis
USA - NYSE:BKD - US1124631045 - Common Stock
9.115 USD
-0.15 (-1.67%)
Taking everything into account, BKD scores 1 out of 10 in our fundamental rating. BKD was compared to 100 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of BKD have multiple concerns. BKD does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
BKD had negative earnings in the past year.
BKD had a positive operating cash flow in the past year.
In the past 5 years BKD reported 4 times negative net income.
BKD had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
With a Return On Assets value of -3.95%, BKD is not doing good in the industry: 64.00% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -230.26%, BKD is doing worse than 79.00% of the companies in the same industry.
With a Return On Invested Capital value of 0.88%, BKD is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.95% | ||
| ROE | -230.26% | ||
| ROIC | 0.88% |
ROA(3y)-3.53%
ROA(5y)-2.19%
ROE(3y)-60.92%
ROE(5y)-37.35%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Operating Margin of BKD (1.94%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of BKD has grown nicely.
With a Gross Margin value of 25.98%, BKD perfoms like the industry average, outperforming 52.00% of the companies in the same industry.
BKD's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.94% | ||
| PM (TTM) | N/A | ||
| GM | 25.98% |
OM growth 3YN/A
OM growth 5Y54.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.08%
GM growth 5Y3.43%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BKD is destroying value.
The number of shares outstanding for BKD has been increased compared to 1 year ago.
Compared to 5 years ago, BKD has more shares outstanding
Compared to 1 year ago, BKD has an improved debt to assets ratio.
2.2 Solvency
BKD has an Altman-Z score of -0.19. This is a bad value and indicates that BKD is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -0.19, BKD is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
A Debt/Equity ratio of 40.40 is on the high side and indicates that BKD has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 40.40, BKD is doing worse than 84.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 40.4 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.19 |
ROIC/WACC0.1
WACC8.52%
2.3 Liquidity
A Current Ratio of 0.83 indicates that BKD may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.83, BKD is doing worse than 85.00% of the companies in the same industry.
BKD has a Quick Ratio of 0.83. This is a bad value and indicates that BKD is not financially healthy enough and could expect problems in meeting its short term obligations.
BKD has a worse Quick ratio (0.83) than 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.83 | ||
| Quick Ratio | 0.83 |
3. Growth
3.1 Past
The earnings per share for BKD have decreased strongly by -14.13% in the last year.
BKD shows a small growth in Revenue. In the last year, the Revenue has grown by 3.90%.
Measured over the past years, BKD shows a decrease in Revenue. The Revenue has been decreasing by -5.08% on average per year.
EPS 1Y (TTM)-14.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5.88%
Revenue 1Y (TTM)3.9%
Revenue growth 3Y4.25%
Revenue growth 5Y-5.08%
Sales Q2Q%4.55%
3.2 Future
The Earnings Per Share is expected to grow by 17.30% on average over the next years. This is quite good.
BKD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.82% yearly.
EPS Next Y9.78%
EPS Next 2Y19.93%
EPS Next 3Y17.3%
EPS Next 5YN/A
Revenue Next Year2.5%
Revenue Next 2Y-0.02%
Revenue Next 3Y0.82%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for BKD. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BKD. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
BKD's Enterprise Value to EBITDA is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 14.19 |
4.3 Compensation for Growth
BKD's earnings are expected to grow with 17.30% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y19.93%
EPS Next 3Y17.3%
5. Dividend
5.1 Amount
No dividends for BKD!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NYSE:BKD (11/6/2025, 11:17:01 AM)
9.115
-0.15 (-1.67%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners98.97%
Inst Owner Change0.9%
Ins Owners0.79%
Ins Owner Change0.02%
Market Cap2.16B
Revenue(TTM)3.19B
Net Income(TTM)-242645000
Analysts51.67
Price Target7.75 (-14.98%)
Short Float %5.62%
Short Ratio4.6
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-87.95%
Min EPS beat(2)-145.33%
Max EPS beat(2)-30.56%
EPS beat(4)0
Avg EPS beat(4)-69%
Min EPS beat(4)-145.33%
Max EPS beat(4)-25.67%
EPS beat(8)1
Avg EPS beat(8)-43.41%
EPS beat(12)4
Avg EPS beat(12)-13.85%
EPS beat(16)6
Avg EPS beat(16)6.19%
Revenue beat(2)0
Avg Revenue beat(2)-1.46%
Min Revenue beat(2)-1.56%
Max Revenue beat(2)-1.36%
Revenue beat(4)0
Avg Revenue beat(4)-1.25%
Min Revenue beat(4)-1.56%
Max Revenue beat(4)-1%
Revenue beat(8)0
Avg Revenue beat(8)-1.07%
Revenue beat(12)0
Avg Revenue beat(12)-0.91%
Revenue beat(16)0
Avg Revenue beat(16)-0.97%
PT rev (1m)1.33%
PT rev (3m)4.83%
EPS NQ rev (1m)3.27%
EPS NQ rev (3m)1.73%
EPS NY rev (1m)1.33%
EPS NY rev (3m)-8.41%
Revenue NQ rev (1m)0.21%
Revenue NQ rev (3m)0.47%
Revenue NY rev (1m)0.12%
Revenue NY rev (3m)0.12%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.68 | ||
| P/FCF | N/A | ||
| P/OCF | 9.9 | ||
| P/B | 20.54 | ||
| P/tB | 27.73 | ||
| EV/EBITDA | 14.19 |
EPS(TTM)-1.05
EYN/A
EPS(NY)-0.5
Fwd EYN/A
FCF(TTM)-1.69
FCFYN/A
OCF(TTM)0.92
OCFY10.1%
SpS13.44
BVpS0.44
TBVpS0.33
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.95% | ||
| ROE | -230.26% | ||
| ROCE | 1.11% | ||
| ROIC | 0.88% | ||
| ROICexc | 0.92% | ||
| ROICexgc | 0.92% | ||
| OM | 1.94% | ||
| PM (TTM) | N/A | ||
| GM | 25.98% | ||
| FCFM | N/A |
ROA(3y)-3.53%
ROA(5y)-2.19%
ROE(3y)-60.92%
ROE(5y)-37.35%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y47.69%
ROICexc growth 3YN/A
ROICexc growth 5Y48.52%
OM growth 3YN/A
OM growth 5Y54.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.08%
GM growth 5Y3.43%
F-Score5
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 40.4 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 9.64 | ||
| Cap/Depr | 163.45% | ||
| Cap/Sales | 19.46% | ||
| Interest Coverage | 0.25 | ||
| Cash Conversion | 49.49% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.83 | ||
| Quick Ratio | 0.83 | ||
| Altman-Z | -0.19 |
F-Score5
WACC8.52%
ROIC/WACC0.1
Cap/Depr(3y)69.44%
Cap/Depr(5y)87.89%
Cap/Sales(3y)8.28%
Cap/Sales(5y)9.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-14.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5.88%
EPS Next Y9.78%
EPS Next 2Y19.93%
EPS Next 3Y17.3%
EPS Next 5YN/A
Revenue 1Y (TTM)3.9%
Revenue growth 3Y4.25%
Revenue growth 5Y-5.08%
Sales Q2Q%4.55%
Revenue Next Year2.5%
Revenue Next 2Y-0.02%
Revenue Next 3Y0.82%
Revenue Next 5YN/A
EBIT growth 1Y24.43%
EBIT growth 3YN/A
EBIT growth 5Y46.37%
EBIT Next Year535.01%
EBIT Next 3Y90.96%
EBIT Next 5YN/A
FCF growth 1Y-274.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y112.46%
OCF growth 3YN/A
OCF growth 5Y-5.14%
BROOKDALE SENIOR LIVING INC / BKD FAQ
What is the ChartMill fundamental rating of BROOKDALE SENIOR LIVING INC (BKD) stock?
ChartMill assigns a fundamental rating of 1 / 10 to BKD.
What is the valuation status for BKD stock?
ChartMill assigns a valuation rating of 1 / 10 to BROOKDALE SENIOR LIVING INC (BKD). This can be considered as Overvalued.
How profitable is BROOKDALE SENIOR LIVING INC (BKD) stock?
BROOKDALE SENIOR LIVING INC (BKD) has a profitability rating of 2 / 10.
Can you provide the financial health for BKD stock?
The financial health rating of BROOKDALE SENIOR LIVING INC (BKD) is 0 / 10.
Can you provide the expected EPS growth for BKD stock?
The Earnings per Share (EPS) of BROOKDALE SENIOR LIVING INC (BKD) is expected to grow by 9.78% in the next year.